16
Views
14
CrossRef citations to date
0
Altmetric
Original Article

0·3 KeV Carbon K Ultrasoft X-rays Are Four Times More Effective than γ-rays When Inducing Oncogenic Cell Transformation at Low Doses

, , , &
Pages 593-601 | Received 18 Jul 1994, Accepted 08 Aug 1995, Published online: 03 Jul 2009
 

Abstract

Oncogenic transformation and inactivation were investigated in C3H10T1/2 mouse embryo fibroblasts exposed to proton-induced 0·28 keV carbon K (CK)-characteristic X-rays and 60Co γ-rays as reference radiation at high dose-rate (2–3 and 0·7 Gy/min respectively). Both oncogenic cell transformation and cell inactivation followed a linear–quadratic relationship with dose. At low doses where the linear component dominates CK ultrasoft X-rays were more effective, by a factor of 4, at inducing oncogenic cell transformation and cell inactivation compared with 60Co γ-rays. For both endpoints the RBE of CK ultrasoft X-rays gradually decreased with increasing dose mainly due to the greater quadratic component for 60Co γ-rays compared with CK ultrasoft X-rays. Our experimental data are in agreement with the hypothesis that single DNA double-strand breaks (dsbs), which are induced by 0·28-keV ultrasoft CK X-rays, may lead to oncogenic cell transformation. With increasing absorbed dose, i.e. with decreasing mean distance between dsbs induced by 0·28-keV ultrasoft X-rays, oncogenic cell transformation and cell inactivation may also be induced by interaction between those dsbs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.